Orgenesis Inc (ORGS)
0.6099
-0.02
(-3.80%)
USD |
NASDAQ |
Jun 28, 16:00
0.6198
+0.01
(+1.62%)
After-Hours: 20:00
Orgenesis Cash from Financing (Quarterly): 3.614M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.614M |
| December 31, 2023 | 1.225M |
| September 30, 2023 | 1.597M |
| June 30, 2023 | 4.886M |
| March 31, 2023 | 5.91M |
| December 31, 2022 | 19.48M |
| September 30, 2022 | 9.189M |
| June 30, 2022 | 10.90M |
| March 31, 2022 | 0.001M |
| December 31, 2021 | -1.095M |
| September 30, 2021 | -0.004M |
| June 30, 2021 | -0.905M |
| March 31, 2021 | 1.898M |
| December 31, 2020 | -0.269M |
| September 30, 2020 | -0.009M |
| June 30, 2020 | -0.198M |
| March 31, 2020 | 6.357M |
| December 31, 2019 | 10.42M |
| September 30, 2019 | -0.114M |
| June 30, 2019 | 7.194M |
| March 31, 2019 | 6.602M |
| November 30, 2018 | 4.549M |
| August 31, 2018 | 19.41M |
| May 31, 2018 | 7.563M |
| February 28, 2018 | 3.54M |
| Date | Value |
|---|---|
| November 30, 2017 | 4.015M |
| August 31, 2017 | 1.996M |
| May 31, 2017 | -0.682M |
| February 28, 2017 | 3.036M |
| November 30, 2016 | 1.806M |
| August 31, 2016 | 1.17M |
| May 31, 2016 | 0.655M |
| February 29, 2016 | -1.508M |
| November 30, 2015 | 5.302M |
| August 31, 2015 | 1.128M |
| May 31, 2015 | 0.25M |
| February 28, 2015 | -0.014M |
| November 30, 2014 | 0.1505M |
| August 31, 2014 | 1.699M |
| May 31, 2014 | 0.20M |
| February 28, 2014 | 0.6876M |
| November 30, 2013 | 0.00 |
| August 31, 2013 | 0.00 |
| May 31, 2013 | 1.55M |
| February 28, 2013 | 0.50M |
| November 30, 2012 | 0.00 |
| August 31, 2012 | 0.50M |
| May 31, 2012 | 0.10M |
| February 29, 2012 | 0.4717M |
| November 30, 2011 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.095M
Minimum
Dec 2021
19.48M
Maximum
Dec 2022
4.004M
Average
1.748M
Median
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 5.025M |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | 1.653M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.441M |
| Cash from Investing (Quarterly) | -0.068M |
| Free Cash Flow | -13.05M |
| Free Cash Flow Per Share (Quarterly) | -0.14 |
| Free Cash Flow to Equity (Quarterly) | -8.36M |
| Free Cash Flow to Firm (Quarterly) | -3.841M |
| Free Cash Flow Yield | -70.29% |